Featured Research

from universities, journals, and other organizations

History Of Broken Bones Overlooked When Treating Osteoporosis

Date:
March 13, 2005
Source:
University Of Alberta
Summary:
Women who need treatment for osteoporosis--thinning of the bones--may not be receiving it because their history of fractures is not being considered by physicians, according to a study done in part at the University of Alberta.

Women who need treatment for osteoporosis--thinning of the bones--may not be receiving it because their history of fractures is not being considered by physicians, according to a study done in part at the University of Alberta.

Previous fractures indicate that bones are weaker than normal, but the information isn't being taken into account when treating for osteoporosis, said Dr. Kerry Siminoski, professor of radiology and diagnostic imaging at the University of Alberta.

The joint study of 1,323 women who were receiving their first ever bone density tests, revealed a 40 per cent gap between those who should have received treatment according to guidelines and the number actually treated. The difference was that those with only borderline bone density problems who had also had past fractures, were not being treated. "To get people who are at the highest risk of osteoporosis, we have to take into account fracture history," Dr. Siminoski said. "We found that it was not being used at all."

Women with previous fractures of the ankle, hip, backbone (which often goes undetected) and especially the wrist after age 20 are two to 10 times more likely to be at future risk of osteoporosis.

Results of the study, which also involved McMaster University and the Centre for Evaluation of Medicines, appear in the February issue of Osteoporosis International.

Bone density tests show how much calcium is in the bones, but fracture history is also valuable in giving a more complete picture, Dr. Siminoski said. "In a way, these people have tested their own bones and shown they have a tendency to break."

Bone densitometry has been widely available for the last ten years, so bone density has tended to be the dominant factor used by physicians in diagnosing and treating the condition, Dr. Siminoski said. "Only now are other factors like fracture history being considered."


Story Source:

The above story is based on materials provided by University Of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University Of Alberta. "History Of Broken Bones Overlooked When Treating Osteoporosis." ScienceDaily. ScienceDaily, 13 March 2005. <www.sciencedaily.com/releases/2005/02/050224124411.htm>.
University Of Alberta. (2005, March 13). History Of Broken Bones Overlooked When Treating Osteoporosis. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/02/050224124411.htm
University Of Alberta. "History Of Broken Bones Overlooked When Treating Osteoporosis." ScienceDaily. www.sciencedaily.com/releases/2005/02/050224124411.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins